Complete Filing Data
LifeStance Health Group, Inc. reported Stockholders Equity Including Portion Attributable To Noncontrolling Interest of $1.52 billion for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean LifeStance Health Group, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Net Income * | $9.7M | -$57.4M | -$186.3M | -$215.6M | -$307.2M | $5.7M | |
| Selling General And Administrative Expense | $382.2M | $363.1M | $410.8M | $378.0M | $433.7M | $41.1M | |
| Revenues | $1.42B | $1.25B | $1.06B | $859.5M | $667.5M | $212.5M | |
| Operating Income Loss | $24.1M | -$31.6M | -$189.1M | -$210.2M | -$286.4M | $15.2M | |
| Operating Expenses | $1.40B | $1.28B | $1.24B | $1.07B | $953.9M | $197.3M | |
| Nonoperating Income Expense | -$11.8M | -$26.0M | -$17.4M | -$22.6M | -$46.8M | -$7.4M | |
| Income Tax Expense Benefit | $2.7M | -$170.0K | -$20.3M | -$17.2M | -$25.9M | $2.2M | |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $12.4M | -$57.6M | -$206.6M | -$232.7M | -$333.1M | $7.9M | |
| Comprehensive Income Net Of Tax | $8.7M | -$58.8M | -$187.2M | -$212.3M | -$307.2M | $5.7M | |
| Income Loss From Continuing Operations Per Diluted Share | $0.02 | -$0.15 | -$0.51 | -$0.61 | -$1.05 | ||
| Income Loss From Continuing Operations Per Basic Share | $0.03 | -$0.15 | -$0.51 | -$0.61 | -$1.05 | ||
| Interest Expense | $21.2M | $19.9M | $38.9M | $5.4M | |||
| Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax | -$929.0K | -$1.4M | -$971.0K | $3.3M | $0.00 | ||
| Other Comprehensive Income Loss Net Of Tax | -$929.0K | -$1.4M | -$971.0K | $3.3M | |||
| Deferred Income Tax Liabilities Net | $16.4M | $14.3M | $15.6M | $38.7M | $54.3M | $81.2M | |
| Income Taxes Paid Net | $1.6M | $57.0K | $80.0K | $2.2M | $1.1M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | $1.1M | -$3.8M | $709.0K | -$6.0M | -$23.3M | -$21.1M | -$61.6M | -$45.5M | -$34.2M | -$37.9M | -$68.7M | -$62.3M | -$120.5M | -$70.0M | -$8.7M | -$3.3M | -$4.3M |
| Selling General And Administrative Expense | $95.6M | $97.4M | $94.4M | $85.3M | $95.2M | $88.9M | $130.9M | $101.9M | $84.6M | $81.2M | $103.6M | $103.4M | $162.9M | $85.5M | $32.7M | $19.5M | $8.6M |
| Revenues | $363.8M | $345.3M | $333.0M | $312.7M | $312.3M | $300.4M | $262.9M | $259.6M | $252.6M | $217.6M | $209.5M | $203.1M | $173.8M | $160.5M | $143.1M | $102.0M | $45.5M |
| Operating Income Loss | $7.4M | -$3.0M | $1.6M | $47.0K | -$15.9M | -$16.8M | -$74.4M | -$48.4M | -$34.1M | -$38.8M | -$60.5M | -$64.9M | -$124.7M | -$47.0M | -$881.0K | $2.7M | $104.0K |
| Operating Expenses | $356.4M | $348.3M | $331.4M | $312.7M | $328.3M | $317.2M | $337.3M | $308.0M | $286.7M | $256.4M | $270.0M | $267.9M | $298.5M | $207.6M | $144.0M | $99.3M | $45.3M |
| Nonoperating Income Expense | -$2.8M | -$3.0M | -$3.1M | -$5.4M | -$6.7M | -$4.0M | -$3.6M | -$3.6M | -$4.2M | -$3.4M | -$7.3M | -$4.2M | -$4.5M | -$26.8M | -$10.6M | -$7.1M | -$5.8M |
| Income Tax Expense Benefit | $3.5M | -$2.2M | -$2.2M | $575.0K | $656.0K | $363.0K | -$16.4M | -$6.5M | -$4.0M | -$4.4M | $923.0K | -$6.7M | -$8.8M | -$3.8M | -$2.8M | -$1.1M | $1.4M |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $4.6M | -$5.9M | -$1.5M | -$5.4M | -$22.6M | -$20.7M | -$78.0M | -$52.0M | -$38.3M | -$42.2M | -$67.8M | -$69.0M | -$129.2M | -$73.8M | -$11.4M | -$4.4M | -$5.7M |
| Comprehensive Income Net Of Tax | $732.0K | -$4.1M | $392.0K | -$7.8M | -$23.5M | -$20.5M | -$61.4M | -$43.3M | -$35.5M | -$34.7M | -$68.7M | -$62.3M | -$120.5M | -$70.0M | -$8.7M | -$3.3M | -$4.3M |
| Income Loss From Continuing Operations Per Diluted Share | $0.00 | -$0.01 | $0.00 | -$0.02 | -$0.06 | -$0.06 | -$0.17 | -$0.13 | -$0.09 | -$0.11 | -$0.19 | -$0.18 | -$0.35 | -$0.22 | |||
| Income Loss From Continuing Operations Per Basic Share | $0.00 | -$0.01 | $0.00 | -$0.02 | -$0.06 | -$0.06 | -$0.17 | -$0.13 | -$0.09 | -$0.11 | -$0.19 | -$0.18 | -$0.35 | -$0.22 | |||
| Interest Expense | $5.8M | $5.9M | $5.5M | $5.1M | $5.1M | $4.2M | $7.1M | $3.4M | $3.5M | $23.2M | $8.6M | $6.4M | $5.6M | ||||
| Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax | -$345.0K | -$267.0K | -$317.0K | -$1.9M | -$243.0K | $583.0K | $230.0K | $2.1M | -$1.3M | $3.2M | $0.00 | $0.00 | $0.00 | ||||
| Other Comprehensive Income Loss Net Of Tax | -$345.0K | -$267.0K | -$317.0K | -$1.9M | -$243.0K | $583.0K | $230.0K | $2.1M | -$1.3M | $3.2M | |||||||
| Deferred Income Tax Liabilities Net | $14.0M | $14.1M | $14.2M | $15.2M | $15.9M | $16.0M | $38.4M | $38.3M | $37.6M | $55.4M | $54.3M | $54.3M | $81.2M | $81.2M | |||
| Income Taxes Paid Net | $609.0K | -$252.0K | -$13.0K | -$60.0K | $3.0K | $25.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $1.52B | $1.45B | $1.43B | $1.52B | $1.55B | $997.8M | -$166.4M | -$109.1M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $248.6M | $154.6M | $78.8M | $108.6M | $148.0M | $18.8M | $3.5M | $11.3M |
| Goodwill | $1.29B | $1.29B | $1.29B | $1.27B | $1.20B | $1.10B | ||
| Repayments Of Long Term Debt | $7.3M | $289.5M | $2.5M | $187.8M | $311.4M | $488.0K | ||
| Purchase Of Property Plant And Equipment Included In Accounts Payable And Accrued Expenses | $2.9M | $1.5M | $3.8M | $7.9M | $15.8M | $1.2M | ||
| Payment For Contingent Consideration Liability Financing Activities | $0.00 | $6.4M | $7.7M | $12.5M | $12.3M | $5.0M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $94.1M | $75.7M | -$29.8M | -$39.4M | $129.2M | -$7.9M | ||
| Retained Earnings Accumulated Deficit | -$808.6M | -$818.3M | -$760.8M | -$572.6M | -$357.1M | -$13.1M | ||
| Property Plant And Equipment Net | $161.6M | $166.0M | $188.2M | $194.2M | $152.2M | $59.3M | ||
| Prepaid Expense And Other Assets Current | $71.8M | $26.1M | $21.5M | $23.7M | $42.4M | $13.7M | ||
| Other Liabilities Noncurrent | $68.0K | $309.0K | $952.0K | $2.8M | $53.6M | $11.4M | ||
| Other Liabilities Current | $14.8M | $7.8M | $3.7M | $2.9M | $2.0M | $5.0M | ||
| Other Accrued Liabilities Current | $42.2M | $46.9M | $35.0M | $30.4M | $26.5M | $14.7M | ||
| Long Term Debt Noncurrent | $265.9M | $279.8M | $280.3M | $225.1M | $157.4M | $362.5M | ||
| Liabilities Noncurrent | $431.0M | $443.1M | $478.2M | $479.1M | $265.3M | $461.0M | ||
| Liabilities Current | $252.0M | $228.9M | $202.9M | $176.0M | $116.8M | $75.9M | ||
| Liabilities And Stockholders Equity | $2.20B | $2.12B | $2.11B | $2.17B | $1.93B | $1.57B | ||
| Liabilities | $682.9M | $672.0M | $681.0M | $655.1M | $382.1M | $536.9M | ||
| Intangible Assets Net Excluding Goodwill | $177.7M | $190.8M | $221.1M | $263.3M | $300.4M | $332.8M | ||
| Employee Related Liabilities Current | $143.3M | $117.5M | $102.5M | $75.7M | $60.0M | $38.0M | ||
| Common Stock Value | $3.9M | $3.8M | $3.8M | $3.8M | $3.7M | $0.00 | ||
| Cash And Cash Equivalents At Carrying Value | $248.6M | $154.6M | $78.8M | $108.6M | $148.0M | $18.8M | ||
| Assets Noncurrent | $1.79B | $1.81B | $1.88B | $1.94B | $1.66B | $1.49B | ||
| Assets Current | $416.2M | $312.5M | $225.7M | $233.2M | $266.5M | $76.3M | ||
| Assets | $2.20B | $2.12B | $2.11B | $2.17B | $1.93B | $1.57B | ||
| Additional Paid In Capital Common Stock | $2.33B | $2.26B | $2.18B | $2.08B | $1.90B | $1.5M | ||
| Accounts Receivable Net Current | $95.7M | $131.8M | $125.4M | $100.9M | $76.1M | $43.7M | ||
| Accounts Payable Current | $6.1M | $7.2M | $7.1M | $12.3M | $14.2M | $7.7M | ||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $1.49B | $1.47B | $1.46B | $1.44B | $1.43B | $1.43B | $1.46B | $1.49B | $1.51B | $1.53B | $1.53B | $1.54B | $1.54B | $1.54B | $954.0M | $999.6M | $981.4M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $203.9M | $188.9M | $134.3M | $102.6M | $87.0M | $49.5M | $42.6M | $79.6M | $68.3M | $90.3M | $96.7M | $114.0M | $212.1M | $276.2M | $39.5M | $25.1M | $13.8M |
| Goodwill | $1.29B | $1.29B | $1.29B | $1.29B | $1.29B | $1.29B | $1.29B | $1.29B | $1.29B | $1.25B | $1.24B | $1.23B | $1.16B | $1.14B | |||
| Repayments Of Long Term Debt | $1.8M | $731.0K | $586.0K | $331.0K | $785.0K | $138.5M | |||||||||||
| Purchase Of Property Plant And Equipment Included In Accounts Payable And Accrued Expenses | $2.3M | $3.1M | $8.3M | $12.3M | $7.5M | $2.7M | |||||||||||
| Payment For Contingent Consideration Liability Financing Activities | $0.00 | $1.7M | $4.3M | $5.7M | $1.5M | $2.2M | |||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$20.2M | -$29.4M | -$40.3M | -$34.0M | $20.7M | $13.8M | |||||||||||
| Retained Earnings Accumulated Deficit | -$820.3M | -$821.4M | -$817.6M | -$811.2M | -$805.2M | -$781.9M | -$715.9M | -$654.3M | -$608.8M | -$526.0M | -$488.1M | -$419.4M | -$249.0M | -$128.6M | |||
| Property Plant And Equipment Net | $162.7M | $160.6M | $163.7M | $170.0M | $175.9M | $182.4M | $190.1M | $193.1M | $193.5M | $193.4M | $190.7M | $170.9M | $115.0M | $91.8M | |||
| Prepaid Expense And Other Assets Current | $35.4M | $40.4M | $29.9M | $26.2M | $23.6M | $18.7M | $71.9M | $36.5M | $25.8M | $49.0M | $47.9M | $54.3M | $46.1M | $27.8M | |||
| Other Liabilities Noncurrent | $105.0K | $182.0K | $254.0K | $381.0K | $571.0K | $760.0K | $855.0K | $2.6M | $2.1M | $67.0M | $64.5M | $57.5M | $22.9M | $15.7M | |||
| Other Liabilities Current | $13.1M | $11.3M | $9.5M | $3.6M | $3.6M | $3.6M | $3.3M | $3.3M | $2.8M | $2.6M | $2.2M | $2.0M | $2.2M | $2.6M | |||
| Other Accrued Liabilities Current | $42.1M | $46.9M | $43.2M | $43.3M | $38.5M | $37.3M | $91.0M | $34.3M | $32.0M | $29.3M | $26.2M | $21.8M | $28.3M | $38.8M | |||
| Long Term Debt Noncurrent | $269.4M | $272.9M | $276.3M | $279.1M | $279.5M | $279.9M | $248.4M | $248.7M | $224.8M | $212.0M | $203.4M | $177.4M | $157.4M | $157.1M | |||
| Liabilities Noncurrent | $427.7M | $430.6M | $440.2M | $453.3M | $461.7M | $469.9M | $479.1M | $495.2M | $472.3M | $335.9M | $325.8M | $290.3M | $264.7M | $257.2M | |||
| Liabilities Current | $228.6M | $242.3M | $207.4M | $217.5M | $227.7M | $207.5M | $240.9M | $180.9M | $181.1M | $112.3M | $111.5M | $125.6M | $105.2M | $112.6M | |||
| Liabilities And Stockholders Equity | $2.15B | $2.15B | $2.10B | $2.11B | $2.12B | $2.11B | $2.18B | $2.17B | $2.16B | $1.98B | $1.97B | $1.96B | $1.91B | $1.91B | |||
| Liabilities | $656.2M | $672.9M | $647.6M | $670.8M | $689.3M | $677.3M | $720.0M | $676.0M | $653.4M | $448.2M | $437.4M | $415.9M | $369.9M | $369.8M | |||
| Intangible Assets Net Excluding Goodwill | $180.8M | $184.0M | $187.3M | $195.4M | $200.1M | $208.5M | $233.6M | $243.8M | $254.0M | $272.5M | $282.1M | $291.2M | $308.0M | $316.5M | |||
| Employee Related Liabilities Current | $113.8M | $129.2M | $99.9M | $111.9M | $122.6M | $100.4M | $83.6M | $81.1M | $83.7M | $61.6M | $61.2M | $73.2M | $57.6M | $50.4M | |||
| Common Stock Value | $3.9M | $3.9M | $3.9M | $3.8M | $3.8M | $3.8M | $3.8M | $3.8M | $3.8M | $3.8M | $3.8M | $3.7M | $3.7M | $3.7M | |||
| Cash And Cash Equivalents At Carrying Value | $203.9M | $188.9M | $134.3M | $102.6M | $87.0M | $49.5M | $42.6M | $79.6M | $68.3M | $90.3M | $96.7M | $114.0M | $212.1M | $276.2M | |||
| Assets Noncurrent | $1.79B | $1.79B | $1.80B | $1.82B | $1.84B | $1.86B | $1.91B | $1.93B | $1.95B | $1.73B | $1.72B | $1.70B | $1.59B | $1.55B | |||
| Assets Current | $360.4M | $358.8M | $304.6M | $287.0M | $277.7M | $244.1M | $264.3M | $237.9M | $212.5M | $252.6M | $244.3M | $263.3M | $328.3M | $364.1M | |||
| Assets | $2.15B | $2.15B | $2.10B | $2.11B | $2.12B | $2.11B | $2.18B | $2.17B | $2.16B | $1.98B | $1.97B | $1.96B | $1.91B | $1.91B | |||
| Additional Paid In Capital Common Stock | $2.31B | $2.29B | $2.27B | $2.24B | $2.23B | $2.20B | $2.16B | $2.14B | $2.11B | $2.05B | $2.02B | $1.96B | $1.79B | $1.67B | |||
| Accounts Receivable Net Current | $121.1M | $129.5M | $140.4M | $158.2M | $167.2M | $175.9M | $149.7M | $121.8M | $118.4M | $113.3M | $99.7M | $95.0M | $70.1M | $60.1M | |||
| Accounts Payable Current | $12.2M | $7.8M | $7.4M | $7.3M | $10.0M | $11.9M | $10.4M | $8.0M | $7.7M | $7.9M | $12.9M | $15.1M | $3.1M | $10.0M | |||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2019 |
|---|---|---|---|---|---|---|
| Share Based Compensation | $74.7M | $76.2M | $99.4M | $187.4M | $259.4M | $54.0K |
| Payments To Acquire Property Plant And Equipment | $36.1M | $21.6M | $40.5M | $79.3M | $94.5M | $14.3M |
| Net Cash Provided By Used In Operating Activities | $146.2M | $107.3M | -$16.9M | $52.8M | $9.4M | $17.0M |
| Net Cash Provided By Used In Investing Activities | -$36.1M | -$21.6M | -$60.3M | -$139.5M | -$194.1M | -$73.4M |
| Net Cash Provided By Used In Financing Activities | -$16.0M | -$9.9M | $47.4M | $47.3M | $313.9M | $48.5M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $46.7M | $3.3M | $3.1M | $3.4M | $29.1M | $2.2M |
| Increase Decrease In Other Accrued Liabilities | -$5.9M | $13.6M | $10.2M | $1.6M | $39.6M | $3.2M |
| Increase Decrease In Accounts Receivable | -$36.1M | $6.4M | $24.2M | $21.7M | $24.2M | $5.8M |
| Increase Decrease In Accounts Payable | -$1.6M | $501.0K | -$5.6M | $7.7M | $623.0K | $2.5M |
| Payments To Acquire Businesses Net Of Cash Acquired | $0.00 | $0.00 | $19.8M | $60.2M | $99.6M | $59.1M |
| Proceeds From Issuance Of Long Term Debt | $0.00 | $287.8M | $57.8M | $257.3M | $98.8M | $55.9M |
| Payments Of Debt Issuance Costs | $0.00 | $1.8M | $188.0K | $7.3M | $2.4M | $2.0M |
| Payments Related To Tax Withholding For Share Based Compensation | $8.7M | $0.00 | $0.00 | $904.0K | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 | Q2 2020 |
|---|---|---|---|---|---|---|
| Share Based Compensation | $18.6M | $20.6M | $23.9M | $59.9M | $605.0K | $292.0K |
| Payments To Acquire Property Plant And Equipment | $7.2M | $5.1M | $7.7M | $27.9M | $11.1M | $5.1M |
| Net Cash Provided By Used In Operating Activities | -$3.1M | -$21.8M | -$7.9M | $3.3M | $9.9M | -$37.3M |
| Net Cash Provided By Used In Investing Activities | -$7.2M | -$5.1M | -$27.5M | -$50.9M | -$11.8M | -$671.2M |
| Net Cash Provided By Used In Financing Activities | -$10.0M | -$2.4M | -$4.9M | $13.5M | $22.6M | $722.3M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $4.5M | -$2.5M | $4.5M | $12.1M | $8.0M | $4.4M |
| Increase Decrease In Other Accrued Liabilities | -$4.4M | $2.8M | $2.0M | $4.9M | $5.9M | -$35.0M |
| Increase Decrease In Accounts Receivable | $8.6M | $50.5M | $17.1M | $18.1M | $3.1M | $2.5M |
| Increase Decrease In Accounts Payable | -$77.0K | $5.0M | -$5.5M | $1.9M | $3.0M | $891.0K |
| Payments To Acquire Businesses Net Of Cash Acquired | $0.00 | $19.8M | $22.9M | $754.0K | $22.4M | |
| Proceeds From Issuance Of Long Term Debt | $0.00 | $20.0M | $26.2M | $235.9M | ||
| Payments Of Debt Issuance Costs | $0.00 | $955.0K | $6.4M | |||
| Payments Related To Tax Withholding For Share Based Compensation | $8.2M | $0.00 | $0.00 | $441.0K | $0.00 | $0.00 |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 386.0M | 379.1M | 367.5M | 355.3M | 327.5K | ||
| Weighted Average Number Of Diluted Shares Outstanding | 391.1M | 379.1M | 367.5M | 355.3M | 327.5K | ||
| Common Stock Shares Issued | 388.3M | 382.7M | 378.7M | 376.0M | 374.3M | 0.00 | 30.2M |
| Common Stock Shares Authorized | 800.0M | 800.0M | 800.0M | 800.0M | 800.0M | 0.00 | 249.8M |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Preferred Stock Shares Authorized | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 0.00 | |
| Preferred Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | |
| Common Stock Shares Outstanding | 388.3M | 382.7M | 378.7M | 376.0M | 374.3M | 0.00 | |
| Common Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 387.0M | 386.7M | 383.3M | 380.4M | 379.4M | 376.3M | 372.5M | 363.2M | 360.9M | 357.5K | 353.7K | 350.8K | 343.4K | 313.5K |
| Weighted Average Number Of Diluted Shares Outstanding | 388.9M | 386.7M | 390.7M | 380.4M | 379.4M | 376.3M | 372.5M | 363.2M | 360.9M | 357.5K | 353.7K | 350.8K | ||
| Common Stock Shares Issued | 389.0M | 389.1M | 388.8M | 382.6M | 383.3M | 382.1M | 378.6M | 378.0M | 376.5M | 376.0M | 376.2M | 374.3M | 374.1M | 374.1M |
| Common Stock Shares Authorized | 800.0M | 800.0M | 800.0M | 800.0M | 800.0M | 800.0M | 800.0M | 800.0M | 800.0M | 800.0M | 800.0M | 800.0M | 800.0M | 800.0M |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Authorized | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M |
| Preferred Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 |
| Common Stock Shares Outstanding | 389.0M | 389.1M | 388.8M | 382.6M | 383.3M | 382.1M | 378.6M | 378.0M | 376.5M | 376.0M | 376.2M | 374.3M | 374.1M | 374.1M |
| Common Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2019 |
|---|---|---|---|---|---|---|
| Other Expenses | $123.0K | $363.0K | $112.0K | $218.0K | $1.5M | $0.00 |
| Depreciation And Amortization | $54.8M | $71.0M | $80.4M | $69.2M | $54.1M | $6.1M |
| Business Combination Remeasurement Gain Loss On Contingent Consideration | $0.00 | $1.7M | $4.0M | -$1.7M | -$2.6M | |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $74.7M | $76.2M | $102.8M | $188.8M | $259.4M | $54.0K |
| Transaction Costs | $0.00 | $827.0K | $89.0K | $722.0K | $3.8M | |
| Other General Expense | $753.6M | $622.5M | $466.0M | $150.1M | ||
| Loss Gain On Remeasurement Of Contingent Consideration | $0.00 | $1.7M | $4.0M | -$1.7M | -$2.6M | $229.0K |
| Interest Paid Net | $17.8M | $25.0M | $21.0M | $14.4M | $22.4M | $4.6M |
| Amortization Of Financing Costs | $1.0M | $1.7M | $2.1M | $1.9M | $1.8M | $707.0K |
| Contingent Consideration Incurred In Acquisitions Of Businesses | $0.00 | $0.00 | $2.0M | $11.2M | $10.7M | $22.9M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Other Expenses | $24.0K | $92.0K | $1.0K | $2.0K | $4.0K | $74.0K | $1.0K | $24.0K | $45.0K | $144.0K | $0.00 | $0.00 | $0.00 | $1.4M | $89.0K | $44.0K | $22.0K |
| Depreciation And Amortization | $13.6M | $14.0M | $13.8M | $15.1M | $18.6M | $22.6M | $19.6M | $19.5M | $19.1M | $17.9M | $16.7M | $15.7M | $13.8M | $12.8M | $12.2M | $10.9M | $5.4M |
| Business Combination Remeasurement Gain Loss On Contingent Consideration | $0.00 | $0.00 | $0.00 | $15.0K | -$55.0K | $2.0M | $1.9M | $1.5M | $1.0M | $1.2M | -$180.0K | -$434.0K | -$906.0K | -$250.0K | -$307.0K | $89.0K | -$51.0K |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $18.3M | $21.1M | $18.6M | $14.9M | $24.6M | $20.6M | $21.5M | $33.1M | $27.2M | $35.7M | $57.5M | $60.0M | $120.7M | $29.5M | $605.0K | $573.0K | $292.0K |
| Transaction Costs | $0.00 | $0.00 | $29.0K | $792.0K | $0.00 | $0.00 | $3.0K | $86.0K | $210.0K | $19.0K | $278.0K | $126.0K | $2.0M | -$1.5M | $683.0K | -$181.0K | |
| Other General Expense | $212.3M | $214.5M | $205.7M | $186.7M | $186.6M | $183.0M | $157.3M | $149.7M | $148.9M | $121.8M | $109.3M | $99.1M | $68.8M | $31.3M | |||
| Loss Gain On Remeasurement Of Contingent Consideration | $0.00 | $2.0M | $1.0M | -$434.0K | -$307.0K | -$51.0K | |||||||||||
| Interest Paid Net | $4.4M | $6.3M | $5.1M | $3.1M | $6.8M | $2.8M | |||||||||||
| Amortization Of Financing Costs | $251.0K | $424.0K | $549.0K | $295.0K | $403.0K | $135.0K | |||||||||||
| Contingent Consideration Incurred In Acquisitions Of Businesses | $0.00 | $2.0M | $2.5M | $808.0K | $3.2M |
Most recent annual filing with the SEC: February 25, 2026
Data sourced from SEC EDGAR public filings as of August 4, 2026.